ArticleFrontiers in cardiovascular medicine2026
Identification of cardiovascular disease in patients with kidney stone disease using explainable machine learning.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kidney stone disease is an independent risk factor for cardiovascular disease (CVD), but specific tools for identifying CVD in patients with kidney stone disease are lacking. This study aimed to validate the association between kidney stones and CVD and to develop an interpretable machine learning model for the identification of prevalent CVD in individuals with kidney stones. Methods: Using data from 34,770 participants in the NHANES 2007-2018 cycle, weighted multivariable logistic regression and subgroup analysis were employed to examine the association between kidney stones and CVD. A total of 1,491 NHANES participants from 2007 to 2016 were used for model development and internal validation, while 296 participants from the 2017-2018 cycle were used as an independent temporal validation cohort. The Shapley Additive exPlanation (SHAP) method was used for global and local interpretation. Results: Model 3 revealed a 47% increased risk of CVD in participants with kidney stones compared to those without (OR = 1.47, 95% CI: 1.20-1.80). In the internal test set, the logistic regression (LR) model performed best, with an area under the receiver operating characteristic curve of 0.801, sensitivity of 0.721, specificity of 0.771, accuracy of 0.759, recall of 0.721, and Brier score of 0.169. LR also demonstrated the best performance in the temporal validation cohort. SHAP analysis identified the importance of 15 predictors. Conclusions: This study highlights an association between kidney stones and prevalent CVD, though causality cannot be inferred due to the cross-sectional design. The LR model demonstrated strong performance in identifying prevalent CVD in patients with kidney stone disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.